Transcription factor PDX-1 in human colorectal adenocarcinoma:A potential tumor marker?
被引:2
|
作者:
Nikiforos Ballian
论文数: 0引用数: 0
h-index: 0
机构:
the Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 1500 Houston,TX 77030, United Statesthe Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 1500 Houston,TX 77030, United States
Nikiforos Ballian
[1
]
Francis Charles Brunicardi
论文数: 0引用数: 0
h-index: 0
机构:
the Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 1500 Houston,TX 77030, United Statesthe Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 1500 Houston,TX 77030, United States
Francis Charles Brunicardi
[1
]
机构:
[1] the Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 1500 Houston,TX 77030, United States
AIM: To examine the expression of pancreatic duodenal homeobox-1 (PDX-1) transcription factor in human colorectal cancer. METHODS: RT-PCR, Western blotting, and immuno-histochemistry were performed to determine the expression pattern of transcription factor PDX-1 in primary colorectal tumor, hepatic metastasis, and benign colon tissue from a single patient. RESULTS: The highest PDX-1 transcription levels were detected in the metastasis material. Lower levels of PDX-1 were found to be present in the primary tumor, while normal colon tissue failed to express detectable levels of PDX-1. Western blot data revealed a PDX-1 expression pattern identical to that of mRNA expression. Immunohistochemistry confirmed high metastasis PDX-1 expression, lower levels in the primary tumor, and the presence of only traces of PDX-1 in normal colon tissue. CONCLUSION: These data argue for further evaluation of PDX-1 as a biomarker for colorectal cancer.